PYPD PolyPid Ltd.
$5.15▼ -0.19%
Healthcare
Other
After hours
$5.25▲ +1.94%
Sep 11, 7:30 PM ET
Volume 99.3K
Avg Volume (10D) 104.1K
Key Metrics & Fundamentals
Market Cap
$104.61M
P/E Ratio
–
Div Yield
–%
52W Range
3.06 - 5.73
% vs 50 MA
5.66%
% vs 200 MA
13.46%
RSI-14
54.5
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.01
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.85M
COGS
–
Operating Exp
$7.85M
Operating Income
-$7.85M
EBIT
-$7.85M
Pretax Income
-$7.84M
Net Income
-$7.85M
EPS (Diluted)
-0.35
Price & Volume History
Loading chart…
Recent News
PolyPid (PYPD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 3:27 PM
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ...
GuruFocus.com · Aug 12, 2026 11:03 PM
PolyPid Ltd. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 9:07 PM
PolyPid Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 4:04 PM
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 12, 2026 11:30 AM
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
GlobeNewswire · Jul 30, 2026 12:00 PM
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
GlobeNewswire · Jul 29, 2026 12:30 PM
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
GlobeNewswire · Jul 21, 2026 1:15 PM
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
GlobeNewswire · Jul 21, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PYPD's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.